TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.

* Furnished herewith.

Tonix Pharmaceuticals Holding Corp. Exhibit
EX-99.01 2 s106751_ex99-1.htm EXHIBIT 99.01   Exhibit 99.01           Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya® as Proposed Brand Name for TNX-102 SL (Cyclobenzaprine HCl Sublingual Tablets) for the Treatment of PTSD   NEW YORK,…
To view the full exhibit click here